VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $289,148 | +119.2% | 53,745 | +171.0% | 0.00% | 0.0% |
| Q4 2022 | $131,896 | +123.6% | 19,834 | +33.7% | 0.00% | – |
| Q3 2022 | $59,000 | -27.2% | 14,834 | -9.0% | 0.00% | -100.0% |
| Q2 2022 | $81,000 | -64.2% | 16,297 | -56.5% | 0.00% | -50.0% |
| Q1 2022 | $226,000 | -55.6% | 37,439 | -14.6% | 0.00% | -50.0% |
| Q4 2021 | $509,000 | +131.4% | 43,819 | +212.9% | 0.00% | +33.3% |
| Q3 2021 | $220,000 | -43.7% | 14,005 | +54.5% | 0.00% | -50.0% |
| Q1 2021 | $391,000 | – | 9,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $73,923,000 | 13.88% |
| RA Capital Management | 11,120,973 | $129,226,000 | 2.28% |
| Paradigm Biocapital Advisors LP | 629,342 | $7,313,000 | 2.09% |
| OUP Management Co., LLC | 374,714 | $4,354,000 | 1.96% |
| JOHNSON & JOHNSON | 1,074,658 | $12,488,000 | 1.42% |
| Sarissa Capital Management LP | 707,010 | $8,215,000 | 0.71% |
| Woodline Partners LP | 1,111,123 | $12,911,000 | 0.18% |
| Artal Group S.A. | 550,000 | $6,391,000 | 0.17% |
| Orbimed Advisors | 833,333 | $9,683,000 | 0.12% |
| Laurion Capital Management LP | 857,308 | $9,962,000 | 0.10% |